Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification

por Zhu VW, Schrock AB, Ali SM, Ou SI
Publicado 2019

Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature

por Klempner SJ, Mehta P, Schrock AB, Ali SM, Ou SI
Publicado 2017

Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation

por Zhu VW, Schrock AB, Bosemani T, Benn BS, Ali SM, Ou SI
Publicado 2018

Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases

por Zhu VW, Nagasaka M, Kubota T, Raval K, Robinette N, Armas O, Al-Holou W, Ou SI
Publicado 2020